Isometric Resistance Exercise for Hypertension
Effectiveness and Mechanisms of Isometric Resistance Exercise to Reduce Blood Pressure in a Chinese Population: a Randomized-controlled Trial
1 other identifier
interventional
390
1 country
2
Brief Summary
Background: Isometric resistance exercises (IREs) have great potential to improve blood pressure (BP) control. However, the effectiveness of IREs in reducing HT is still unknown because their hypotensive effects have not been detected using ambulatory BP measurements (ABPM), which are the current standard for BP measurement. Methods: This first adequately-powered RCT will involve 390 patients with HT who do not meet the current physical activity guidelines defined by the World Health Organization. Participants will be randomly assigned in a 1:1 ratio using stratified and blocked randomization to either the IRE (wall squat) group or stretching exercise (active control) group. A well-structured, widely accepted, and validated 24-week wall squat program (2 minutes per exercise, 2 minutes of rest between sets, and 3 sessions per week) will be implemented, as it has been commonly used in previous research. Adherence to the program will be monitored using smartwatches, and regular contact with patients through social media will help ensure adherence. All patients will be followed up for 1 year to investigate the long-term effects of IREs on BP. Control group will receive exact same treatment except that IRE is replaced by frequency-matched and time-matched stretching exercise. The primary outcome measure will be systolic daytime ABPM BP at 24 weeks. Secondary outcome measures will include other BP and ABPM parameters at 12 weeks, 24weeks and 1year, cfPWV at baseline, 24 weeks and 1year, and FMD at baseline and 24weeks. Safety data will be collected and reported.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jan 2025
Typical duration for not_applicable hypertension
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
July 19, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 28, 2027
December 29, 2025
February 1, 2025
2.6 years
July 15, 2024
December 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
daytime systolic blood pressure (BP) assessed via ambulatory blood pressure monitoring (ABPM)
systolic blood pressure (SBP) measured from a 24-h ABPM
24-week after recruitment (immediate post-intervention)
Secondary Outcomes (3)
Other blood pressure indices
24-week, 1 year
Carotid-femoral pulse wave velocity
24-week after recruitment (immediate post-intervention), 1 year
flow-mediated dilation of brachial artery (FMD)
24-week after recruitment (immediate post-intervention), 1 year
Study Arms (2)
Isometric exercise
EXPERIMENTAL2 minutes wall squat, with 2 minutes rest between sets * to perform 4 sets in total/day * at least 3 days/week * totally for 24-weeks
passive stretching
ACTIVE COMPARATOR14 minutes passive stretching * at least 3 days/week * totally 24-weeks
Interventions
Each exercise session will contain 4 sets of 2-minute wall squat isometric holds with 2 minutes of rest between each set (approximately 14 minutes per session in total), and a total of 3 sessions will be arranged every week (with ideally 48 h between exercises)
A frequency-matched (3x/week) and time-matched (\~14 minutes each session) passive static stretching exercise will be used
Eligibility Criteria
You may qualify if:
- a suboptimal daytime SBP of \>135-160 mmHg on a 24-h ABPM
- reported no regular physical activity or less than that recommended for adults by the World Health Organization (e.g. \<150 minutes of moderate-intensity aerobic exercise per week)
- on stable doses of anti-HT medication(s) for ≥4 weeks if the patient is receiving drug treatments;
- agree for no drug changes during the intervention period (24 weeks);
You may not qualify if:
- cannot provide informed consent
- unwillingness to repeat ABPM
- relative contraindications to ABPM (i.e. diagnosed atrial fibrillation, nighttime workers, occupational drivers, or patients with bleeding tendencies)
- severe osteoarthritis pending knee replacement surgery
- known secondary HT
- use of ≥3 anti-HT medications at maximum doses or ≥4 anti-HT medications
- SBP or DBP are \>160 mmHg or \>100 mmHg, respectively, on ABPM at baseline or at 12 weeks follow-up to ensure safety
- pregnancy/breastfeeding
- active malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Lek Yuen General Outpatient Clinic
Hong Kong, 00000, Hong Kong
School of public health and primary care
Hong Kong, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical associate professor
Study Record Dates
First Submitted
July 15, 2024
First Posted
July 19, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
July 28, 2027
Study Completion (Estimated)
September 28, 2027
Last Updated
December 29, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share